Related Experiment Video
Updated: Jan 14, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastoma
Neil Savage1,2, Etienne Danis3,4, Chirayu R Chokshi1,2
1Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8N 3Z5, Canada.
Abstract:
Glioblastoma (GBM) remains a formidable challenge in clinical settings due to limited treatments available. The surface protein CD133 marks glioblastoma stem cells (GSCs), cells capable of overcoming therapeutic pressures and correlate with more aggressiveness tumor phenotypes. In this study, we employed a CRISPR-Cas9 functional screen to deconvolute CD133 dynamics in tumors. This led us to establish that SOX2 is a key player in controlling the PROM1 gene, which in turn influences how cells react to stress factors, including those induced by chemoradiation treatment. The discoveries in this study shed light on the complex web of mechanisms that control the survival and resistance of GSCs, offering promising new avenues for targeting and potentially overcoming therapy resistance.
Insights
Glioblastoma stem cells (GSCs) survival is linked to SOX2, which controls PROM1. This finding offers new strategies to overcome therapy resistance in glioblastoma (GBM) treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioblastoma (GBM) presents significant treatment challenges.
- Glioblastoma stem cells (GSCs), marked by CD133, drive tumor aggressiveness and therapy resistance.
Purpose of the Study:
- To investigate the regulatory mechanisms of CD133 dynamics in glioblastoma.
- To identify key factors influencing glioblastoma stem cell survival and resistance to treatment.
Main Methods:
- Utilized a CRISPR-Cas9 functional screen to analyze CD133 regulation.
- Investigated the role of SOX2 in controlling PROM1 gene expression.
Main Results:
- Identified SOX2 as a critical regulator of the PROM1 gene.
- Demonstrated that SOX2-PROM1 axis influences glioblastoma stem cell response to chemoradiation stress.
Conclusions:
- SOX2 plays a pivotal role in glioblastoma stem cell survival and therapeutic resistance.
- Targeting the SOX2-PROM1 pathway presents a potential strategy to overcome glioblastoma treatment resistance.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR
Regulation of Expression at Multiple Steps
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

